N
Northgold AB
STO:NG
Northgold AB
STO:NG
Price:
0.562
SEK
5.64%
Market Closed
Market Cap:
kr12.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Northgold AB
STO:NG
|
SE |
|
Tetra Bio Pharma Inc
TSX:TBP
|
CA |
|
E
|
Empyrean Energy PLC
LSE:EME
|
AU |
|
P
|
Philippine Seven Corp
XPHS:SEVN
|
PH |
|
Nanovibronix Inc
NASDAQ:NAOV
|
US |
|
C
|
China Sunsine Chemical Holdings Ltd
SGX:QES
|
SG |
|
Pharnext SCA
OTC:PNEXF
|
FR |
|
G
|
Gapwaves AB
STO:GAPW B
|
SE |
|
V
|
Vinyl Chemicals India Ltd
NSE:VINYLINDIA
|
IN |
|
FRONTEO Inc
TSE:2158
|
JP |
|
J
|
Jiangsu Times Textile Technology Co Ltd
SZSE:001234
|
CN |
|
Want Want China Holdings Ltd
HKEX:151
|
CN |
Balance Sheet
Balance Sheet Decomposition
Northgold AB
Northgold AB
Balance Sheet Decomposition is not available for
Northgold AB
Northgold AB
Balance Sheet
Northgold AB
Northgold AB
Currency: SEK
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
0
|
1
|
13
|
3
|
2
|
|
| Cash Equivalents |
0
|
1
|
13
|
3
|
2
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
1
|
3
|
1
|
|
| Total Current Assets |
0
|
1
|
14
|
4
|
3
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
11
|
23
|
52
|
35
|
|
| Goodwill |
0
|
1
|
1
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
1
|
0
|
|
| Other Assets |
0
|
1
|
1
|
0
|
0
|
|
| Total Assets |
0
N/A
|
13
+26 087%
|
38
+182%
|
57
+52%
|
39
-32%
|
|
| Liabilities | ||||||
| Accounts Payable |
0
|
0
|
1
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
2
|
3
|
6
|
2
|
|
| Total Current Liabilities |
0
|
3
|
4
|
8
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
3
+40 309%
|
4
+64%
|
8
+87%
|
3
-61%
|
|
| Equity | ||||||
| Common Stock |
0
|
1
|
1
|
1
|
2
|
|
| Retained Earnings |
0
|
4
|
28
|
53
|
78
|
|
| Additional Paid In Capital |
0
|
14
|
49
|
77
|
87
|
|
| Other Equity |
0
|
0
|
11
|
24
|
26
|
|
| Total Equity |
0
N/A
|
11
+23 888%
|
33
+212%
|
49
+48%
|
36
-27%
|
|
| Total Liabilities & Equity |
0
N/A
|
13
+26 087%
|
38
+182%
|
57
+52%
|
39
-32%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
11
|
11
|
11
|
14
|
23
|
|
Switch to:
Switch to:
See Also
Discover More
